Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
115747235 | 11574723 | 5 | F | 201501 | 20160819 | 20150930 | 20160824 | PER | US-PFIZER INC-2015293777 | PFIZER | 56.00 | YR | F | Y | 74.00000 | KG | 20160824 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
115747235 | 11574723 | 1 | PS | LYRICA | PREGABALIN | 1 | 150 MG, 2X/DAY | N46086 | 21446 | 150 | MG | CAPSULE, HARD | BID | ||||||
115747235 | 11574723 | 2 | SS | LYRICA | PREGABALIN | 1 | 150 MG, 2X/DAY | 21446 | 150 | MG | CAPSULE, HARD | BID | |||||||
115747235 | 11574723 | 3 | SS | LYRICA | PREGABALIN | 1 | 150 MG, 2X/DAY | 21446 | 150 | MG | CAPSULE, HARD | BID | |||||||
115747235 | 11574723 | 4 | SS | LYRICA | PREGABALIN | 1 | Oral | 150 MG, 2X/DAY | 21446 | 150 | MG | CAPSULE, HARD | BID | ||||||
115747235 | 11574723 | 5 | SS | LYRICA | PREGABALIN | 1 | Oral | 150 MG, 2X/DAY | 21446 | 150 | MG | CAPSULE, HARD | BID | ||||||
115747235 | 11574723 | 6 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG, DAILY | 0 | 40 | MG | MODIFIED-RELEASE CAPSULE, HARD | |||||||
115747235 | 11574723 | 7 | C | METFORMIN HCL | METFORMIN HYDROCHLORIDE | 1 | Oral | 1000 MG, 1X/DAY | 0 | 1000 | MG | TABLET | QD | ||||||
115747235 | 11574723 | 8 | C | OXYCODONE | OXYCODONE | 1 | UNK | 0 | |||||||||||
115747235 | 11574723 | 9 | C | VOLTAREN | DICLOFENAC SODIUM | 1 | 600 MG, 3X/DAY | 0 | 600 | MG | TID | ||||||||
115747235 | 11574723 | 10 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 600 MG, 3X/DAY | 0 | 600 | MG | TABLET | TID | ||||||
115747235 | 11574723 | 11 | C | WELCHOL | COLESEVELAM HYDROCHLORIDE | 1 | Oral | 625 MG, 1X/DAY | 0 | 625 | MG | TABLET | QD | ||||||
115747235 | 11574723 | 12 | C | CYANOCOBALAMIN. | CYANOCOBALAMIN | 1 | 1000 UG/ML, MONTHLY | 0 | INJECTION | /month | |||||||||
115747235 | 11574723 | 13 | C | CYANOCOBALAMIN. | CYANOCOBALAMIN | 1 | 1000 UG/ML, MONTHLY | 0 | INJECTION | /month | |||||||||
115747235 | 11574723 | 14 | C | CYANOCOBALAMIN. | CYANOCOBALAMIN | 1 | Sublingual | 2500 UG, DAILY | 0 | 2500 | UG | TABLET | |||||||
115747235 | 11574723 | 15 | C | ERGOCALCIFEROL. | ERGOCALCIFEROL | 1 | Oral | 50000 IU, WEEKLY (50000UNIT CAPSULE, 1 ORAL) | 0 | 50000 | IU | CAPSULE | /wk | ||||||
115747235 | 11574723 | 16 | C | DICLOFENAC SODIUM. | DICLOFENAC SODIUM | 1 | Oral | 75 MG, 2X/DAY | 0 | 75 | MG | TABLET | BID | ||||||
115747235 | 11574723 | 17 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Oral | 60 MG, DAILY | 0 | 60 | MG | CAPSULE | |||||||
115747235 | 11574723 | 18 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | TABLET | QD | ||||||
115747235 | 11574723 | 19 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 20 MG, 1X/DAY | 0 | 20 | MG | TABLET | QD | ||||||
115747235 | 11574723 | 20 | C | IPRATROPIUM BROMIDE. | IPRATROPIUM BROMIDE | 1 | UNK, AS NEEDED ((0.02% SOLUTION, 1 (ONE) INHALATION EVERY FOUR HOURS) | 0 | |||||||||||
115747235 | 11574723 | 21 | C | ALBUTEROL SULFATE. | ALBUTEROL SULFATE | 1 | UNK, AS NEEDED ((1.25MG/3 ML NEBULIZED SOLN, 1 (ONE) NEBULIZED SOLN INHALATION EVERY FOUR HOURS) | 0 | INHALATION VAPOUR, SOLUTION | ||||||||||
115747235 | 11574723 | 22 | C | FISH OIL | FISH OIL | 1 | Oral | 1000 MG, 2X/DAY | 0 | 1000 | MG | CAPSULE | BID | ||||||
115747235 | 11574723 | 23 | C | VALIUM | DIAZEPAM | 1 | Oral | 10 MG, AS NEEDED (FOUR TIMES DAILY) | 0 | 10 | MG | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
115747235 | 11574723 | 1 | Fibromyalgia |
115747235 | 11574723 | 6 | Dyspepsia |
115747235 | 11574723 | 11 | Blood cholesterol abnormal |
115747235 | 11574723 | 12 | Vitamin supplementation |
115747235 | 11574723 | 15 | Vitamin D deficiency |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
115747235 | 11574723 | Arthralgia | |
115747235 | 11574723 | Back pain | |
115747235 | 11574723 | Drug ineffective | |
115747235 | 11574723 | Gait disturbance | |
115747235 | 11574723 | Hyperaesthesia | |
115747235 | 11574723 | Intentional product misuse | |
115747235 | 11574723 | Muscle spasms | |
115747235 | 11574723 | Musculoskeletal stiffness | |
115747235 | 11574723 | Neck pain | |
115747235 | 11574723 | Pain | |
115747235 | 11574723 | Swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
115747235 | 11574723 | 1 | 201501 | 0 | ||
115747235 | 11574723 | 2 | 2015 | 0 | ||
115747235 | 11574723 | 3 | 20151016 | 0 | ||
115747235 | 11574723 | 4 | 20150923 | 0 | ||
115747235 | 11574723 | 5 | 20150112 | 0 | ||
115747235 | 11574723 | 6 | 20150923 | 0 | ||
115747235 | 11574723 | 7 | 20150112 | 0 | ||
115747235 | 11574723 | 10 | 20150112 | 0 | ||
115747235 | 11574723 | 11 | 20150611 | 0 | ||
115747235 | 11574723 | 12 | 20150629 | 0 | ||
115747235 | 11574723 | 13 | 20151009 | 0 | ||
115747235 | 11574723 | 14 | 20150513 | 0 | ||
115747235 | 11574723 | 15 | 20150112 | 0 | ||
115747235 | 11574723 | 16 | 20150112 | 0 | ||
115747235 | 11574723 | 17 | 20150112 | 0 | ||
115747235 | 11574723 | 18 | 20141031 | 0 | ||
115747235 | 11574723 | 19 | 20150711 | 0 | ||
115747235 | 11574723 | 20 | 20150112 | 0 | ||
115747235 | 11574723 | 21 | 20150112 | 0 | ||
115747235 | 11574723 | 22 | 20150812 | 0 | ||
115747235 | 11574723 | 23 | 20150910 | 0 |